Home
Conditions
Recurrent Non-small Cell Lung Cancer

Clinical trial condition

Recurrent Non-small Cell Lung Cancer

Explore clinical trials studying Recurrent Non-small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

69 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Recurrent Non-small Cell Lung Cancer trial results

Completed

AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy

NCT00638937

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

The Ottawa Hospital Cancer Centre (Ottawa Health Research Institute) Civic Campus Ottawa, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

McGill University Department of Oncology Montreal, Quebec, Canada

View Trial Details

Completed

Frailty Index and Geriatric Assessment in Predicting Toxicity to Front-Line Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

NCT01026467

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Syracuse VA Medical Center Syracuse, New York, United States

Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

Docetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT01557959

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Adenocarcinoma of the Lung, +22 more
Locations: Wake Forest University Health Sciences Winston-Salem, North Carolina, United States

View Trial Details

Completed

AZD2171 and Pemetrexed Disodium in Treating Patients With Relapsed Non-Small Cell Lung Cancer

NCT00410904

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States

Wayne State University/Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Completed

Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

NCT00138203

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: St. Vincent Regional Cancer Center CCOP Green Bay, Wisconsin, United States

Gundersen Lutheran La Crosse, Wisconsin, United States

UW Health Oncology - 1 South Park Madison, Wisconsin, United States

University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States

View Trial Details

Completed

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

NCT00093756

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

Saint Francis Hospital and Medical Center Hartford, Connecticut, United States

Mayo Clinic in Florida Jacksonville, Florida, United States

Rush - Copley Medical Center Aurora, Illinois, United States

View all 143 locations

View Trial Details

Completed

Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer

NCT00362882

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: City of Hope Medical Center Duarte, California, United States

View Trial Details

Completed

Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

NCT01948141

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

University Hospitals Case Medical Center Cleveland, Ohio, United States

View Trial Details

Completed

Imatinib Mesylate and Paclitaxel in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00408460

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
Locations: University of New Mexico Cancer Center Albuquerque, New Mexico, United States

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Erlotinib Hydrochloride With or Without Celecoxib in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer

NCT00499655

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations: City of Hope Medical Center Duarte, California, United States

South Pasadena Cancer Center South Pasadena, California, United States

View Trial Details

Recurrent Non-small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer trial results

Related conditions